The Activation of CD14, TLR4, and TLR2 by MmLDL Induces IL-1β, IL-6, and IL-10 Secretion in Human Monocytes and Macrophages

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2010 Oct 16

PMID 20946675

Citations 32

Authors

Luis Chavez-Sanchez

Karina Chavez-Rueda

Maria Victoria Legorreta-Haquet

Edgar Zenteno

Yadira Ledesma-Soto

Eduardo Montoya-Diaz

Emiliano Tesoro-Cruz

Alejandra Madrid-Miller

Francisco Blanco-Favela

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Atherosclerosis is considered a chronic inflammatory disease in which monocytes and macrophages are critical. These cells express CD14, toll-like receptor (TLR) 2, and TLR4 on their surfaces, are activated by minimally modified low-density lipoprotein (mmLDL) and are capable of secreting pro-inflammatory cytokines. The aim of this research was thus to demonstrate that the activation of CD14, TLR2, and TLR4 by mmLDL induces the secretion of cytokines.

Methods: Human monocytes and macrophages were incubated with monoclonal antibodies specific for CD14, TLR4, and TLR2 prior to stimulation with mmLDL. Cytokine secretion was then compared to that observed upon mmLDL stimulation in untreated cells.

Results: Stimulation with mmLDL induced the secretion of pro-inflammatory cytokines. Blocking CD14 in monocytes inhibited secretion of interleukin (IL)-1β (72%), IL-6 (58%) and IL-10 (63%), and blocking TLR4 inhibited secretion of IL-1β by 67%, IL-6 by 63% and IL-10 by 60%. Blocking both receptors inhibited secretion of IL-1β by 73%, IL-6 by 69% and IL-10 by 63%. Furthermore, blocking TLR2 inhibited secretion of IL-1β by 65%, IL-6 by 62% and IL-10 by 75%. In macrophages, we found similar results: blocking CD14 inhibited secretion of IL-1β by 59%, IL-6 by 52% and IL-10 by 65%; blocking TLR4 inhibited secretion of IL-1β by 53%, IL-6 by 63% and IL-10 by 61%; and blocking both receptors inhibited secretion of IL-1β by 69%, IL-6 by 67% and IL-10 by 65%. Blocking TLR2 in macrophages inhibited secretion of IL-1β by 57%, IL-6 by 40% and IL-10 by 72%.

Conclusion: Our study demonstrates that CD14, TLR4, and TLR2 participate in the immune response against mmLDL by inducing the production of pro-inflammatory cytokines in both monocytes and macrophages. These findings suggest that the activation of these receptors by mmLDL contributes to the inflammatory process of atherosclerosis.

Citing Articles

Lipopolysaccharide Effects on Neurotransmission: Understanding Implications for Depression.

Batey L, Baumberger B, Khoshbouei H, Hashemi P ACS Chem Neurosci. 2024; 15(24):4339-4347.

PMID: 39601433 PMC: 11660149. DOI: 10.1021/acschemneuro.4c00591.

Exogenous heat shock proteins HSPA1A and HSPB1 regulate TNF-α, IL-1β and IL-10 secretion from monocytic cells.

Ogbodo E, Michelangeli F, Williams J FEBS Open Bio. 2023; 13(10):1922-1940.

PMID: 37583307 PMC: 10549225. DOI: 10.1002/2211-5463.13695.

Monocytic Cell Adhesion to Oxidised Ligands: Relevance to Cardiovascular Disease.

Poston R, Chughtai J, Ujkaj D, Louis H, Leake D, Cooper D Biomedicines. 2022; 10(12).

PMID: 36551839 PMC: 9775297. DOI: 10.3390/biomedicines10123083.

Chimeric Virus-like Particles Co-Displaying Hemagglutinin Stem and the C-Terminal Fragment of DnaK Confer Heterologous Influenza Protection in Mice.

Liu C, Liu D, Yue X, Zhong X, Wu X, Chang H Viruses. 2022; 14(10).

PMID: 36298664 PMC: 9610613. DOI: 10.3390/v14102109.

The Mechanism of Lung and Intestinal Injury in Acute Pancreatitis: A Review.

Liu D, Wen L, Wang Z, Hai Y, Yang D, Zhang Y Front Med (Lausanne). 2022; 9:904078.

PMID: 35872761 PMC: 9301017. DOI: 10.3389/fmed.2022.904078.

References

Virella G, Atchley D, Koskinen S, Zheng D, Lopes-Virella M . Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL. Clin Immunol. 2002; 105(1):81-92. DOI: 10.1006/clim.2002.5269. View

Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y . Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2003; 23(4):656-60. DOI: 10.1161/01.ATV.0000064374.15232.C3. View

Pugin J, Heumann I, Tomasz A, Kravchenko V, Akamatsu Y, Nishijima M . CD14 is a pattern recognition receptor. Immunity. 1994; 1(6):509-16. DOI: 10.1016/1074-7613(94)90093-0. View

Tabas I . Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2009; 10(1):36-46. PMC: 2854623. DOI: 10.1038/nri2675. View

Iwami K, Matsuguchi T, Masuda A, Kikuchi T, Musikacharoen T, Yoshikai Y . Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J Immunol. 2000; 165(12):6682-6. DOI: 10.4049/jimmunol.165.12.6682. View

Chavez-Sanchez L, Madrid-Miller A, Chavez-Rueda K, Legorreta-Haquet M, Tesoro-Cruz E, Blanco-Favela F . Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response. Hum Immunol. 2010; 71(8):737-44. DOI: 10.1016/j.humimm.2010.05.005. View

Pentikainen M, Lindstedt K, Kovanen P . Inhibition of the oxidative modification of LDL by nitecapone. Arterioscler Thromb Vasc Biol. 1995; 15(6):740-7. DOI: 10.1161/01.atv.15.6.740. View

Woollard K, Geissmann F . Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010; 7(2):77-86. PMC: 2813241. DOI: 10.1038/nrcardio.2009.228. View

Segura M, Vadeboncoeur N, Gottschalk M . CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin Exp Immunol. 2002; 127(2):243-54. PMC: 1906344. DOI: 10.1046/j.1365-2249.2002.01768.x. View

10.

Kol A, Lichtman A, Finberg R, Libby P . Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol. 1999; 164(1):13-7. DOI: 10.4049/jimmunol.164.1.13. View

11.

Dong C, Davis R, Flavell R . MAP kinases in the immune response. Annu Rev Immunol. 2002; 20:55-72. DOI: 10.1146/annurev.immunol.20.091301.131133. View

12.

Sims J, Smith D . The IL-1 family: regulators of immunity. Nat Rev Immunol. 2010; 10(2):89-102. DOI: 10.1038/nri2691. View

13.

Pasini A, Anselmi M, Garbin U, Franchi E, Stranieri C, Nava M . Enhanced levels of oxidized low-density lipoprotein prime monocytes to cytokine overproduction via upregulation of CD14 and toll-like receptor 4 in unstable angina. Arterioscler Thromb Vasc Biol. 2007; 27(9):1991-7. DOI: 10.1161/ATVBAHA.107.142695. View

14.

Netea M, Kullberg B, Jacobs L, Verver-Jansen T, van der Ven-Jongekrijg J, Galama J . Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release. J Immunol. 2004; 173(2):1477-82. DOI: 10.4049/jimmunol.173.2.1477. View

15.

Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N . Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2004; 50(5):1457-67. DOI: 10.1002/art.20219. View

16.

Beg A . Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 2002; 23(11):509-12. DOI: 10.1016/s1471-4906(02)02317-7. View

17.

Hodgkinson C, Laxton R, Patel K, Ye S . Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler Thromb Vasc Biol. 2008; 28(12):2275-81. DOI: 10.1161/ATVBAHA.108.175992. View

18.

Chi H, Barry S, Roth R, Wu J, Jones E, Bennett A . Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(7):2274-9. PMC: 1413743. DOI: 10.1073/pnas.0510965103. View

19.

Gabay C . Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006; 8 Suppl 2:S3. PMC: 3226076. DOI: 10.1186/ar1917. View

20.

Libby P . Inflammation in atherosclerosis. Nature. 2002; 420(6917):868-74. DOI: 10.1038/nature01323. View